The U.S. Supreme Court ruled against the drugmaker Wyeth (WYE.N) on Wednesday, holding that pharmaceutical companies can be held liable for harm from medicines that carry warnings approved by federal regulators.
By a 6-to-3 vote in a major defeat for the pharmaceutical industry, the high court ruled that U.S. Food and Drug Administration labeling approvals do not pre-empt state laws and shield companies from damages as part of liability claims.
US Supreme Court: FDA-approved labels no legal shield
After recently gaining recognition as the first professional Santa Claus with Down syndrome in the US,...
As a new NFL season begins this Wednesday, the danger of America’s most-watched sport has never...
